Publication | Closed Access

A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer

Phase Ib/iiGastrointestinal OncologyMedicineMetronomic TherapyPathologyWeekly PaclitaxelFallopian TubeCancer TreatmentOncologyRadiation OncologyOvarian Cancer